Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)

Q. Zhao; M. M.E. Jongsma; S. A. Vuijk; B. C.M. de Winter; C. Martinez-Vinson; K. L. Kolho; Lorenzo Norsa; S. Hussey; Eytan Wine; Shlomi Cohen; Dror S. Shouval; Amit Assa; R. Lev-Tzion; Tim de Meij; Victorien M. Wolters; Hien Q. Huynh; T. Preijers; L. de Ridder

doi:10.1007/s40262-025-01599-w

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)

Q. Zhao
, M. M.E. Jongsma
, S. A. Vuijk
, B. C.M. de Winter
, C. Martinez-Vinson
, K. L. Kolho
, Lorenzo Norsa
, S. Hussey
, Eytan Wine
, Shlomi Cohen
, Dror S. Shouval
, Amit Assa
, R. Lev-Tzion
, Tim de Meij
, Victorien M. Wolters
, Hien Q. Huynh
, T. Preijers
, L. de Ridder^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

11 Downloads (Pure)

Abstract

In this article the author’s name Victorien M. Wolters was incorrectly written without the mid-initial as Victorien Wolters. The original article has been corrected.

Original language	English
Pages (from-to)	167
Number of pages	1
Journal	Clinical Pharmacokinetics
Volume	65
Issue number	1
Early online date	28 Nov 2025
DOIs	https://doi.org/10.1007/s40262-025-01599-w
Publication status	Published - 28 Nov 2025

Access to Document

10.1007/s40262-025-01599-wLicence: CC BY-NC

s40262-025-01599-wFinal published version, 382 KBLicence: CC BY-NC

Fingerprint

Dive into the research topics of 'Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)'. Together they form a unique fingerprint.

1 Article

Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration
Zhao, Q., Jongsma, M. M. E., Vuijk, S. A., de Winter, B. C. M., Martinez-Vinson, C., Kolho, K. L., Norsa, L., Hussey, S., Wine, E., Cohen, S., Shouval, D. S., Assa, A., Lev-Tzion, R., de Meij, T., Wolters, V., Huynh, H. Q., Preijers, T. & de Ridder, L., Jan 2026, In: Clinical Pharmacokinetics. 65, 1, p. 81-95 15 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
1 Downloads (Pure)

Cite this

Zhao, Q., Jongsma, M. M. E., Vuijk, S. A., de Winter, B. C. M., Martinez-Vinson, C., Kolho, K. L., Norsa, L., Hussey, S., Wine, E., Cohen, S., Shouval, D. S., Assa, A., Lev-Tzion, R., de Meij, T., Wolters, V. M., Huynh, H. Q., Preijers, T., & de Ridder, L. (2025). Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6). Clinical Pharmacokinetics, 65(1), 167. https://doi.org/10.1007/s40262-025-01599-w

Zhao, Q. ; Jongsma, M. M.E. ; Vuijk, S. A. et al. / Correction : Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6). In: Clinical Pharmacokinetics. 2025 ; Vol. 65, No. 1. pp. 167.

@article{62ff5fdbf19548399da78520f0792189,

title = "Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)",

abstract = "In this article the author{\textquoteright}s name Victorien M. Wolters was incorrectly written without the mid-initial as Victorien Wolters. The original article has been corrected.",

author = "Q. Zhao and Jongsma, \{M. M.E.\} and Vuijk, \{S. A.\} and \{de Winter\}, \{B. C.M.\} and C. Martinez-Vinson and Kolho, \{K. L.\} and Lorenzo Norsa and S. Hussey and Eytan Wine and Shlomi Cohen and Shouval, \{Dror S.\} and Amit Assa and R. Lev-Tzion and \{de Meij\}, Tim and Wolters, \{Victorien M.\} and Huynh, \{Hien Q.\} and T. Preijers and \{de Ridder\}, L.",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = nov,

day = "28",

doi = "10.1007/s40262-025-01599-w",

language = "English",

volume = "65",

pages = "167",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "1",

}

Zhao, Q, Jongsma, MME, Vuijk, SA, de Winter, BCM, Martinez-Vinson, C, Kolho, KL, Norsa, L, Hussey, S, Wine, E, Cohen, S, Shouval, DS, Assa, A, Lev-Tzion, R, de Meij, T, Wolters, VM, Huynh, HQ, Preijers, T & de Ridder, L 2025, 'Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)', Clinical Pharmacokinetics, vol. 65, no. 1, pp. 167. https://doi.org/10.1007/s40262-025-01599-w

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6). / Zhao, Q.; Jongsma, M. M.E.; Vuijk, S. A. et al.
In: Clinical Pharmacokinetics, Vol. 65, No. 1, 28.11.2025, p. 167.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction

T2 - Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)

AU - Zhao, Q.

AU - Jongsma, M. M.E.

AU - Vuijk, S. A.

AU - de Winter, B. C.M.

AU - Martinez-Vinson, C.

AU - Kolho, K. L.

AU - Norsa, Lorenzo

AU - Hussey, S.

AU - Wine, Eytan

AU - Cohen, Shlomi

AU - Shouval, Dror S.

AU - Assa, Amit

AU - Lev-Tzion, R.

AU - de Meij, Tim

AU - Wolters, Victorien M.

AU - Huynh, Hien Q.

AU - Preijers, T.

AU - de Ridder, L.

PY - 2025/11/28

Y1 - 2025/11/28

N2 - In this article the author’s name Victorien M. Wolters was incorrectly written without the mid-initial as Victorien Wolters. The original article has been corrected.

AB - In this article the author’s name Victorien M. Wolters was incorrectly written without the mid-initial as Victorien Wolters. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/105023554929

U2 - 10.1007/s40262-025-01599-w

DO - 10.1007/s40262-025-01599-w

M3 - Comment/Letter to the editor

C2 - 41313575

AN - SCOPUS:105023554929

SN - 0312-5963

VL - 65

SP - 167

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 1

ER -

Zhao Q, Jongsma MME, Vuijk SA, de Winter BCM, Martinez-Vinson C, Kolho KL et al. Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6). Clinical Pharmacokinetics. 2025 Nov 28;65(1):167. Epub 2025 Nov 28. doi: 10.1007/s40262-025-01599-w

Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration (Clinical Pharmacokinetics, (2025), 10.1007/s40262-025-01565-6)

Abstract

Access to Document

Other files and links

Fingerprint

Research output

Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration

Cite this